CSNK2B and congenital myasthenic syndrome: Knockdown (KD) of HIKER/LINC02228 and its downstream target, the casein kinase 2 (CK2) β unit (CSNK2B), caused a severe reduction of EE response in CMS cells under hypoxic conditions.